PURPOSE: [(11)C]Carfentanil has been widely used in positron emission tomography (PET) studies for measuring micro-opioid receptor binding in humans, but the reproducibility of the binding parameter estimates is unknown. MATERIALS AND METHODS: Eight healthy volunteers were scanned twice during the same day with [(11)C]carfentanil PET, and binding to receptors was assessed with both reference tissue and arterial plasma input-based models using region of interest (ROI) and voxel-based quantification. RESULTS: The two-tissue compartmental model distribution volume (V(T)) was highly reproducible as indicated by low variability (VAR < 6%) and high intraclass correlation coefficients (ICC > 0.93). BP(ND) (BP relative to the nondisplaceable tissue compartment) was also highly reproducible (VAR < 10%, ICC > 0.90) both at ROI- and voxel-level, and reference tissue-based models provided stable estimates after 40 min. CONCLUSIONS: The reproducibility of [(11)C]carfentanil binding parameter estimates is excellent with outcome measures based on both arterial plasma and reference tissue input, and a scanning time of 40 min appears sufficient.
PURPOSE:[(11)C]Carfentanil has been widely used in positron emission tomography (PET) studies for measuring micro-opioid receptor binding in humans, but the reproducibility of the binding parameter estimates is unknown. MATERIALS AND METHODS: Eight healthy volunteers were scanned twice during the same day with [(11)C]carfentanil PET, and binding to receptors was assessed with both reference tissue and arterial plasma input-based models using region of interest (ROI) and voxel-based quantification. RESULTS: The two-tissue compartmental model distribution volume (V(T)) was highly reproducible as indicated by low variability (VAR < 6%) and high intraclass correlation coefficients (ICC > 0.93). BP(ND) (BP relative to the nondisplaceable tissue compartment) was also highly reproducible (VAR < 10%, ICC > 0.90) both at ROI- and voxel-level, and reference tissue-based models provided stable estimates after 40 min. CONCLUSIONS: The reproducibility of [(11)C]carfentanil binding parameter estimates is excellent with outcome measures based on both arterial plasma and reference tissue input, and a scanning time of 40 min appears sufficient.
Authors: Robert B Innis; Vincent J Cunningham; Jacques Delforge; Masahiro Fujita; Albert Gjedde; Roger N Gunn; James Holden; Sylvain Houle; Sung-Cheng Huang; Masanori Ichise; Hidehiro Iida; Hiroshi Ito; Yuichi Kimura; Robert A Koeppe; Gitte M Knudsen; Juhani Knuuti; Adriaan A Lammertsma; Marc Laruelle; Jean Logan; Ralph Paul Maguire; Mark A Mintun; Evan D Morris; Ramin Parsey; Julie C Price; Mark Slifstein; Vesna Sossi; Tetsuya Suhara; John R Votaw; Dean F Wong; Richard E Carson Journal: J Cereb Blood Flow Metab Date: 2007-05-09 Impact factor: 6.200
Authors: B N Dhawan; F Cesselin; R Raghubir; T Reisine; P B Bradley; P S Portoghese; M Hamon Journal: Pharmacol Rev Date: 1996-12 Impact factor: 25.468
Authors: J J Frost; H N Wagner; R F Dannals; H T Ravert; J M Links; A A Wilson; H D Burns; D F Wong; R W McPherson; A E Rosenbaum Journal: J Comput Assist Tomogr Date: 1985 Mar-Apr Impact factor: 1.826
Authors: J K Zubieta; Y R Smith; J A Bueller; Y Xu; M R Kilbourn; D M Jewett; C R Meyer; R A Koeppe; C S Stohler Journal: Science Date: 2001-07-13 Impact factor: 47.728
Authors: J J Frost; K H Douglass; H S Mayberg; R F Dannals; J M Links; A A Wilson; H T Ravert; W C Crozier; H N Wagner Journal: J Cereb Blood Flow Metab Date: 1989-06 Impact factor: 6.200
Authors: Jon-Kar Zubieta; Terence A Ketter; Joshua A Bueller; Yanjun Xu; Michael R Kilbourn; Elizabeth A Young; Robert A Koeppe Journal: Arch Gen Psychiatry Date: 2003-11
Authors: Tiina Saanijoki; Lauri Nummenmaa; Jetro J Tuulari; Lauri Tuominen; Eveliina Arponen; Kari K Kalliokoski; Jussi Hirvonen Journal: Hum Brain Mapp Date: 2018-06-08 Impact factor: 5.038
Authors: Lauri Tuominen; Lauri Nummenmaa; Liisa Keltikangas-Järvinen; Olli Raitakari; Jarmo Hietala Journal: Hum Brain Mapp Date: 2013-05-14 Impact factor: 5.038
Authors: Mary Falcone; Allison B Gold; E Paul Wileyto; Riju Ray; Kosha Ruparel; Andrew Newberg; Jacob Dubroff; Jean Logan; Jon-Kar Zubieta; Julie A Blendy; Caryn Lerman Journal: Psychopharmacology (Berl) Date: 2012-03-03 Impact factor: 4.530
Authors: Riju Ray; Kosha Ruparel; Andrew Newberg; E Paul Wileyto; James W Loughead; Chaitanya Divgi; Julie A Blendy; Jean Logan; Jon-Kar Zubieta; Caryn Lerman Journal: Proc Natl Acad Sci U S A Date: 2011-05-16 Impact factor: 11.205
Authors: Jarkko Johansson; Jussi Hirvonen; Zsófia Lovró; Laura Ekblad; Valtteri Kaasinen; Olli Rajasilta; Semi Helin; Jouni Tuisku; Saija Sirén; Mirka Pennanen; Arvind Agrawal; Roger Crystal; Petri J Vainio; Hannu Alho; Mika Scheinin Journal: Neuropsychopharmacology Date: 2019-03-13 Impact factor: 7.853
Authors: Tiina Saanijoki; Lauri Tuominen; Jetro J Tuulari; Lauri Nummenmaa; Eveliina Arponen; Kari Kalliokoski; Jussi Hirvonen Journal: Neuropsychopharmacology Date: 2017-07-19 Impact factor: 7.853
Authors: Owen Carmichael; Adam J Schwarz; Christopher H Chatham; David Scott; Jessica A Turner; Jaymin Upadhyay; Alexandre Coimbra; James A Goodman; Richard Baumgartner; Brett A English; John W Apolzan; Preetham Shankapal; Keely R Hawkins Journal: Drug Discov Today Date: 2017-11-15 Impact factor: 7.851
Authors: Lars Farde; Pontus Plavén-Sigray; Jacqueline Borg; Simon Cervenka Journal: Philos Trans R Soc Lond B Biol Sci Date: 2018-04-19 Impact factor: 6.237
Authors: Talakad G Lohith; Sami S Zoghbi; Cheryl L Morse; Maria D Ferraris Araneta; Vanessa N Barth; Nancy A Goebl; Johannes T Tauscher; Victor W Pike; Robert B Innis; Masahiro Fujita Journal: Neuroimage Date: 2013-11-10 Impact factor: 6.556